Atrial Fibrillation: An Overview on Abnormal Rapid Heart Rhythm

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
J. Marcus Wharton, MD, director of clinical cardiac electrophysiology at the Medical University of South Carolina, talks about the symptoms, causes, and consequences of atrial fibrillation.

To listen to this podcast, click here.
Related Articles
Digoxin increases risk of death in patients with newly diagnosed atrial fibrillation.
Researchers evaluated more than 2 decades of evidence on atrial fibrillation patients taking vitamin K antagonists.
Researchers evaluated the risk of cardiovascular outcomes in atrial fibrillation patients with a history of falls.
Latest Issues
$auto_registration$